Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $89.4 million.

  • Altimmune's Shares Outstanding (Weighted Average) rose 2579.07% to $89.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.4 million, marking a year-over-year increase of 2579.07%. This contributed to the annual value of $71.0 million for FY2024, which is 3334.74% up from last year.
  • According to the latest figures from Q3 2025, Altimmune's Shares Outstanding (Weighted Average) is $89.4 million, which was up 2579.07% from $81.5 million recorded in Q2 2025.
  • In the past 5 years, Altimmune's Shares Outstanding (Weighted Average) registered a high of $89.4 million during Q3 2025, and its lowest value of $38.9 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $50.7 million (2023), whereas its average is $57.3 million.
  • Per our database at Business Quant, Altimmune's Shares Outstanding (Weighted Average) surged by 15753.46% in 2021 and then surged by 670.33% in 2025.
  • Quarter analysis of 5 years shows Altimmune's Shares Outstanding (Weighted Average) stood at $41.3 million in 2021, then rose by 13.67% to $46.9 million in 2022, then rose by 13.47% to $53.2 million in 2023, then soared by 33.35% to $71.0 million in 2024, then rose by 25.93% to $89.4 million in 2025.
  • Its last three reported values are $89.4 million in Q3 2025, $81.5 million for Q2 2025, and $75.5 million during Q1 2025.